|
Glioblastoma
|
|
|
|
M. J. van
den Bent, W. Grisold, D. Frappaz, R.
Stupp, J. P. Desir, T. Lesimple, C.
Dittrich, M. J. A. de Jonge, A. Brandes,
M. Frenay, A. F. Carpentier, P. Chollet,
J. Oliveira, B. Baron, D. Lacombe,
M. Schuessler and P. Fumoleau
European
Organization for Research and Treatment of Cancer (EORTC) open label phase
II study on glufosfamide administered as a 60-minute infusion every 3
weeks in recurrent glioblastoma multiforme
Annals
of Oncology 14:1732-1734, December
2003
|
|
